Clinical Trial Update: A Comparison of Efficacy and Safety During Endoscopic Submucosal Dissection Between Dexmedetomidine-remifentanil and Propofol-remifentanil [NA]

View source ↗

Summary

Completed clinical trial comparing two anesthesia regimens (dexmedetomidine-remifentanil vs propofol-remifentanil) used during endoscopic submucosal dissection …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Dexmedetomidine + Remifentanil regimen
• Propofol + Remifentanil regimen

Snippet

Sponsor: Yonsei University | Conditions: Early Gastric Cancer Patients Who Were Scheduled for Endoscopic Submucosal Dissection | NA | Status: COMPLETED